About this item:

66 Views | 45 Downloads

Author Notes:

May D. Wang, Email: maywang@gatech.edu

J.V., contributed to the study design, the pre-processing, data analysis for the EHR data, the combination of the three data modalities, and the writing of the manuscript, including Figs. ​Figs.1,1, ​,2,2, ​,33 and the Tables. L.T., contributed to the pre-processing and analysis of the SNP data, the writing of the manuscipt (including background and discussions, sections related to SNP results and pre-processing including Fig. 4, and relevant figures in the supplementary section), and the revision of the manuscript. H.H. contributed to the image processing pipeline and writing of the results pertaining to image processing, including the relevant figures in supplementary section. Prof. M.D.W., contributed to the study design, result evaluation, and extensive refining and the revision of the manuscript.

The authors declare no competing interests.

Subjects:

Research Funding:

The work was supported in part by Petit Institute Faculty Fellow Fund, Carol Ann and David D. Flanagan Faculty Fellow Research Fund, Amazon Faculty Research Fellowship. This work was also supported in part by the scholarship from China Scholarship Council (CSC) under the Grant CSC NO. 201406010343. The content of this article is solely the responsibility of the authors.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • DIABETIC-RETINOPATHY
  • CEREBROSPINAL-FLUID
  • FEATURE-SELECTION
  • DIAGNOSIS
  • CLASSIFICATION
  • BIOMARKERS
  • REPRESENTATION
  • VALIDATION
  • CRITERIA
  • PREDICT

Multimodal deep learning models for early detection of Alzheimer's disease stage

Tools:

Journal Title:

SCIENTIFIC REPORTS

Volume:

Volume 11, Number 1

Publisher:

, Pages 3254-3254

Type of Work:

Article | Final Publisher PDF

Abstract:

Most current Alzheimer’s disease (AD) and mild cognitive disorders (MCI) studies use single data modality to make predictions such as AD stages. The fusion of multiple data modalities can provide a holistic view of AD staging analysis. Thus, we use deep learning (DL) to integrally analyze imaging (magnetic resonance imaging (MRI)), genetic (single nucleotide polymorphisms (SNPs)), and clinical test data to classify patients into AD, MCI, and controls (CN). We use stacked denoising auto-encoders to extract features from clinical and genetic data, and use 3D-convolutional neural networks (CNNs) for imaging data. We also develop a novel data interpretation method to identify top-performing features learned by the deep-models with clustering and perturbation analysis. Using Alzheimer’s disease neuroimaging initiative (ADNI) dataset, we demonstrate that deep models outperform shallow models, including support vector machines, decision trees, random forests, and k-nearest neighbors. In addition, we demonstrate that integrating multi-modality data outperforms single modality models in terms of accuracy, precision, recall, and meanF1 scores. Our models have identified hippocampus, amygdala brain areas, and the Rey Auditory Verbal Learning Test (RAVLT) as top distinguished features, which are consistent with the known AD literature.

Copyright information:

© The Author(s) 2021

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote